Quest Diagnostics (FRA:QDI) Net Income (Continuing Operations): €958 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:QDI Quest Diagnostics Inc FRA:QDI
75 GF Score
Price €209.10
GF Value €168.34
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Quest Diagnostics Net Income (Continuing Operations)?

Quest Diagnostics FRA:QDI -0.10% 75 Net Income (Continuing Operations) is €958 Mil as of Jun. 2026. GuruFocus rates FRA:QDI with a GF Score™ of 75/100 and a GF Value™ of €168.34 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Quest Diagnostics's Net Income (Continuing Operations) for the three months ended in Jun. 2026 was €290 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jun. 2026 was €958 Mil.

Quest Diagnostics  (FRA:QDI) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Quest Diagnostics Net Income (Continuing Operations) Related Terms

Quest Diagnostics Net Income (Continuing Operations) Historical Data

* Premium members only.

The historical data trend for Quest Diagnostics's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest Diagnostics Net Income (Continuing Operations) Chart

Quest Diagnostics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Income (Continuing Operations)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,840.80 958.16 832.64 879.56 893.28

Quest Diagnostics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 256.63 220.67 218.62 228.36 289.91
FRA:QDI
75GF Score
Quest Diagnostics Inc FRA:QDI
Net Income (Continuing Operations) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Quest Diagnostics Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €958 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Net Income (Continuing Operations) of €958 Mil mean?
Quest Diagnostics (FRA:QDI) has a Net Income (Continuing Operations) of €958 Mil as of Jun. 2026. Net Income (Continuing operations) is the total net earnings from a company's continuing operations. View historical data on Quest Diagnostics and its competitors.
Is Quest Diagnostics' Net Income (Continuing Operations) too high?
Quest Diagnostics' current Net Income (Continuing Operations) is €958 Mil. Overall, Quest Diagnostics has a GF Score™ of 75/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Quest Diagnostics' Net Income (Continuing Operations) compare to LH and MTD?
Quest Diagnostics' Net Income (Continuing Operations) of €958 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Income (Continuing Operations) for a Medical Diagnostics & Research company?
A good Net Income (Continuing Operations) depends on the Medical Diagnostics & Research industry context. However, Net Income (Continuing Operations) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Income (Continuing Operations) mean?
A high Net Income (Continuing Operations) can signal that a stock is expensive relative to its fundamentals. Net Income (Continuing operations) is the total net earnings from a company's continuing operations. View historical data on Quest Diagnostics and its competitors. Quest Diagnostics's current Net Income (Continuing Operations) is €958 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Quest Diagnostics (FRA:QDI) is currently considered Modestly Overvalued. The stock's GF Value™ is €168.34, compared to a current price of €209.10 — trading 24.2% above its estimated fair value. The current Net Income (Continuing Operations) is €958 Mil. Quest Diagnostics' overall GF Score™ is 75/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Income (Continuing Operations) calculated?
Net Income (Continuing Operations) is calculated from a company's financial statements. For Quest Diagnostics (FRA:QDI), the current Net Income (Continuing Operations) is €958 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Quest Diagnostics (FRA:QDI) Overvalued in 2026?

Based on GuruFocus' analysis, Quest Diagnostics stock appears to be overvalued. The current stock price of €209.10 is trading 24.2% above its estimated GF Value™ of €168.34. GuruFocus considers Quest Diagnostics to be Modestly Overvalued.

Key valuation signals for FRA:QDI:

  • Net Income (Continuing Operations): €958 Mil
  • GF Value™: €168.34 vs. price of €209.10 (24.2% above fair value)
  • GF Score™: 75/100 with 7 warning signs

No single metric tells the full story. See the FRA:QDI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Quest Diagnostics Business Description

Address 500 Plaza Drive, Secaucus, NJ, USA, 07094
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
75GF Score

Get the complete analysis for FRA:QDI

Net Income (Continuing Operations) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€209.10
Price
€168.34
GF Value